Fintel reports that on March 7, 2025, Scotiabank initiated coverage of Zai Lab Limited - Depositary Receipt ... With coverage of over 75,000 listed companies on all major stock exchanges ...

Scotiabank initiated coverage on shares of Zai Lab (NASDAQ:ZLAB – Free Report) in a research note issued to investors on Friday morning, Ratings reports. The firm issued a sector outperform rating and ...

Zai Lab Announces Acceptance of Biologics License Application for TIVDAK for the Treatment of Patients with Recurrent or Metastatic Cervical Cancer ...

Zai Lab (ZLAB – Research Report) received a Buy rating and a $55.00 price target from Scotiabank analyst Louise Chen today. The company’s ...

Zai Lab (ZLAB) “announced that China’s National Medical Products Administration has accepted the Biologics License Application for TIVDAK, ...

Shares of ZLAB opened at $35.39 on Tuesday. Zai Lab has a one year low of $13.48 and a one year high of $36.60. The stock has a 50-day moving average price of $28.10 and a 200 day moving average ...

Investors in Zai Lab Limited (NASDAQ:ZLAB) had a good week, as its shares rose 2.5% to close at US$34.64 following the release of its annual results. Revenue hit US$399m in line with forecasts ...

Zai Lab (NASDAQ:ZLAB – Get Free Report)‘s stock had its “neutral” rating reiterated by research analysts at Bank of America in a note issued to investors on Monday, MarketBeat reports. They presently ...

Research analysts at Cantor Fitzgerald issued their FY2025 EPS estimates for shares of Zai Lab in a research report issued to clients and investors on Tuesday, March 4th. Cantor Fitzgerald analyst L.

Goldman Sachs analysts added Zai Lab (ZLAB) to the firm’s APAC Conviction List as part of its monthly update. The firm says the company is ...

Profitability Target: Expected to achieve profitability in Q4 2025. Zai Lab Ltd (NASDAQ:ZLAB) reported a 50% year-over-year revenue growth for 2024, with a 66% increase in the fourth quarter alone.

Investors in Zai Lab Limited (NASDAQ:ZLAB) had a good week, as its shares rose 2.5% to close at US$34.64 following the release of its annual results. Revenue hit US$399m in line with forecasts, ...